Renal failure therapy system having electrically floating fluid pathway
US-11116067-B2 · Sep 7, 2021 · US
US11696386B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11696386-B2 |
| Application number | US-202117466386-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 3, 2021 |
| Priority date | Oct 14, 2015 |
| Publication date | Jul 4, 2023 |
| Grant date | Jul 4, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A renal failure therapy system having an electrically floating fluid pathway is disclosed. The example system includes a dialyzer, a blood circuit in fluid communication with the dialyzer, and a dialysis fluid circuit in fluid communication with the dialyzer. The system also includes an electrically floating fluid pathway comprising at least a portion of the blood circuit and at least a portion of the dialysis fluid circuit. The only electrical path to ground is via used dialysis fluid traveling through the renal failure therapy system to earth ground. The disclosed system enables at least one electrical component in the at least a portion of the dialysis fluid circuit of the electrically floating fluid pathway to be electrically bypassed.
Opening claim text (preview).
The invention is claimed as follows: 1. A renal failure therapy system comprising: a dialyzer; a blood circuit in fluid communication with the dialyzer; a dialysis fluid circuit in fluid communication with the dialyzer; and an electrically floating fluid pathway comprising at least a portion of the blood circuit and at least a portion of the dialysis fluid circuit, wherein the only electrical path to ground is via used dialysis fluid traveling through the renal failure therapy system to earth ground, and wherein at least one electrical component in the at least a portion of the dialysis fluid circuit of the electrically floating fluid pathway is electrically bypassed. 2. The renal failure therapy system of claim 1 , wherein (i) the electrically bypassed portion of the dialysis fluid circuit of the electrically floating fluid pathway is electrically short circuited or (ii) the electrical component is of a type sensitive to electrical disturbances. 3. The renal failure therapy system of claim 1 , wherein the electrically bypassed portion of the dialysis fluid circuit of the electrically floating fluid pathway includes (i) at least one electrical line placed in parallel with the at least one electrical component, (ii) a small passage formed between a fluid inlet and a fluid outlet of the at least one electrical component, or (iii) a conductor located between a fluid inlet and a fluid outlet of the at least one electrical component. 4. The renal failure therapy system of claim 3 , wherein the at least one electrical line placed in parallel with the at least one electrical component includes upstream and downstream conductive couplers placed in fluid lines upstream and downstream, respectively, of the electrical component, and wherein the electrical line is extended from the upstream conductive coupler to the downstream conductive coupler. 5. The renal failure therapy system of claim 1 , wherein the at least one electrical component includes a conductivity sensor having a conductivity probe that contacts dialysis fluid flowing through the at least a portion of the dialysis fluid circuit. 6. The renal failure therapy system of claim 1 , wherein the at least one electrical component includes a flowmeter for measuring the flowrate of dialysis fluid flowing through the at least a portion of the dialysis fluid circuit. 7. The renal failure therapy system of claim 1 , wherein the at least a portion of the dialysis fluid circuit includes at least a portion of a fresh dialysis fluid line and at least a portion of a used dialysis fluid line. 8. The renal failure therapy system of claim 7 , further comprising at least one electrically bypassed electrical component in the at least a portion of the fresh dialysis fluid line and at least one electrically bypassed electrical component in the at least a portion of the used dialysis fluid line. 9. The renal failure therapy system of claim 7 , wherein the electrically floating fluid pathway includes an electrical line extending from the at least a portion of the fresh dialysis fluid line to the at least a portion of the used dialysis fluid line, the electrical line positioned to bypass the dialyzer and a patient to be treated. 10. The renal failure therapy system of claim 7 , further comprising an electrical bypass from the fresh dialysis fluid line to the used dialysis fluid line, such that a fault current generated in the fresh dialysis fluid line bypasses the dialyzer via the electrical bypass to the used dialysis fluid line. 11. The renal failure therapy system of claim 10 , wherein the electrical bypass is (i) located between a furthest downstream fluid component of the fresh dialysis fluid line and the dialyzer, or (ii) located between a furthest upstream fluid component of the used dialysis fluid line and the dialyzer. 12. The renal failure therapy system of claim 10 , wherein the electrically floating fluid pathway includes at least one additional electrical bypass that shunts current away from the at least one electrical component located in the fresh or used dialysis fluid lines. 13. The renal failure therapy system of claim 1 , wherein the electrically floating fluid pathway includes at least one selected from the group consisting of an arterial line, a venous line, arterial and venous needles, a fresh dialysis fluid line, a fresh dialysis fluid tube, liquid concentrate lines, concentrate sources when liquid concentrate sources are used, a water line, a water source when the water is non-deionized, a used dialysis fluid tube, and a used dialysis fluid line. 14. The renal failure therapy system of claim 1 , wherein the electrically floating fluid pathway is connected to an external drain line, which leads to an electrically grounded drain. 15. The renal failure therapy system of claim 1 , wherein the electrically floating fluid pathway includes at least one fluid component that is not electrically bypassed, but which is electrically insulated from a chassis of the system to form a delineated applied part. 16. A renal failure therapy system comprising: a dialyzer; a blood circuit in fluid communication with the dialyzer; a dialysis fluid circuit in fluid communication with the dialyzer; an electrically floating fluid pathway comprising at least a portion of the dialysis fluid circuit, wherein the only electrical path to ground is via used dialysis fluid traveling through the renal failure therapy system to the ground, and wherein at least one electrical component in the at a least portion of the dialysis fluid circuit of the electrically floating fluid pathway is electrically insulated; and a testing structure configured to test whether the electrically floating fluid pathway has been compromised via an undesired electrical connection to the ground, wherein the testing structure includes a generator selected from the group consisting of a current generator and a voltage generator, and a meter selected from the group consisting of a voltage meter and a current meter, wherein the system is programmed to use (i) the generator to set a limit and (ii) the meter to determine if the limit has been reached, and wherein the meter is placed in electrical communication with first and second bypasses that shunt current away from the at least one electrical component located in fresh or used dialysis fluid lines of the dialysis fluid circuit. 17. The renal failure therapy system of claim 16 , further comprising a switch in electrical communication with the generator, wherein the switch is closed before treatment for (i) and opened during treatment for (ii). 18. The renal failure therapy system of claim 16 , wherein the testing structure includes an electrical path from at least one bypass bypassing the at least one electrical component to the ground, and wherein the current meter is located in the electrical path.
Extra-corporeal blood circuits (single-needle circuits A61M1/30) · CPC title
User interfaces, e.g. screens or keyboards · CPC title
Temperature · CPC title
with membranes · CPC title
with testing or calibration facilities · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.